Background: Tracheostomy following congenital heart disease (CHD) surgery is a rare event and associated with significant mortality. Hospital survival has been reported from 20% to 40%. Late mortality for these patients is not well characterized.
Introduction
Outcomes following surgery for pediatric congenital heart disease (CHD) have improved in the last decade, with a current overall survival of 96.6%. 1 The majority of patients recover from surgery and are weaned from mechanical ventilation postoperatively. A small number of patients require prolonged respiratory support, necessitating the consideration of placement of a tracheostomy. Published reports of patients requiring tracheostomy have ranged from 0.2% to 2.7%. [2] [3] [4] [5] [6] Data from the Society for Thoracic Surgeons registry demonstrate that only 0.7% of patients who required a Norwood operation had a subsequent tracheostomy. 7 The indication for tracheostomy in pediatric patients is often multifactorial, and in many cases, the procedure is only performed after prolonged periods of invasive positive pressure ventilation. Genetic syndromes associated with CHD (such as 22q11, trisomy 21, CHARGE (coloboma, heart defect, choanal atresia, retarded growth & development, genetic abnormality, ear deformity), and VACTERL (vertebral defects, anal atresia, cardiac defects, tracheo-esophageal fistula, renal anomalies, limb abnormalities)) can predispose affected children to airway problems. Surgical complications including recurrent laryngeal nerve injury, diaphragmatic paralysis, and persistent chylothorax have been associated with tracheostomy. [8] [9] [10] [11] [12] In the population with CHD, there is often residual cardiac disease that exacerbates an underlying pulmonary process. 9 Without a clear indication for tracheostomy, prolonged mechanical ventilation and multiple extubation failures usually occur. The timing of tracheostomy is highly variable among studies. 3, 5, 13, 14 This practice variation may be due in part to perceived high mortality associated with tracheostomy and the difficulty in separating the numerous cardiopulmonary interactions that occur in patients with CHD.
Hospital survival following CHD surgery and tracheostomy is reported at approximately 65% to 80%. 2, 3, 5, 15, 16 Hospital survival of more complicated lesions and single-ventricle patients after tracheostomy has been reported at 50% to 75%. 2, 16 Other groups of pediatric patients who require tracheostomy (including infants with prolonged intensive care unit stays for prematurity and related complications) have an 80% to 90% survival and a 30% to 70% chance of weaning from positive pressure ventilation. [17] [18] [19] [20] Although patients with tracheostomy and CHD are likely at higher risk of death than other pediatric patients, precise comparisons are unknown.
The objective of this retrospective review of a single center's experience with tracheostomy following surgery for CHD was to compare associated comorbidities and outcomes for patients with single-ventricle and biventricular physiological repairs who required tracheostomy following surgery. The authors hypothesize that most patients with CHD who require tracheostomy will have significant comorbid illnesses and other complications. Single-ventricle repairs are likely at greater risk for diminished short-and long-term survival and weaning from positive pressure ventilation.
Materials and Methods
A retrospective observational study of all children <18 years of age requiring tracheostomy following surgery for CHD at Riley Hospital for Children at Indiana University Health between January 1, 2000, and December 31, 2013, was performed. Premature infants who required an isolated patent ductus arteriosus ligation with no other CHD were excluded. Patient follow-up was included until March 2015. The hospital clinical information system was queried for all patients who had surgery for CHD and then limited to those with subsequent tracheostomy using the International Classification of Disease, Revision 9, Clinical Modification procedure codes (31.1 and 31.2). This list was compared against a registry of cardiac surgical patients and a database of patients maintained by the home mechanical ventilation program. The study was approved and exempted by the institutional review board of Indiana University School of Medicine.
Riley Hospital has over three decades of experience in both the medical and surgical management of CHD. The modern surgical program performs over 600 procedures annually on approximately 360 patients. The chronic mechanical ventilation program has managed over 700 patients since its inception in 1984. It adds approximately 25 new patients each year with a variety of pediatric respiratory disease. Patients are seen regularly by a multidisciplinary team from the time of tracheostomy until they are weaned from positive pressure ventilation.
Medical records were reviewed for baseline demographics, cardiac diagnosis, congenital heart procedures, and comorbidities. The most hemodynamically significant congenital heart lesion was characterized. The first operation for CHD during the hospitalization when the tracheostomy occurred was used as the index operation. Secondary operations were noted both during and subsequent to that hospitalization. The primary diagnosis, ensuing surgical repairs, and in limited cases echocardiography reports were used to group patients with CHD into single-ventricle and biventricular physiology groups. 2 The subset of biventricular physiology patients with conotruncal disease are listed separately in Table 1 , but their characteristics and outcomes mirrored those of the other biventricular groups, and so were combined for analysis.
Comorbidities were common in this population and categorized for descriptive purposes after reviewing the medical record. Genetic syndromes including DiGeorge, CHARGE, VACTERL, trisomy 21, and heterotaxy were recorded if present. Prematurity for infants born less than 37 weeks was documented. Pulmonary complications, either congenital or acquired, included upper airway anatomic abnormalities, lower airway malacia (of the trachea or bronchi), and chronic lung disease. These categories were often part of the indication for tracheostomy. In many patients, pulmonary disease was present in multiple categories. Pulmonary hypertension was documented on echocardiography or heart catheterization. Because of the complex interaction of acquired/congenital respiratory disease, pulmonary hypertension, and residual cardiac disease, no attempt was made to identify a primary indication for tracheostomy. Patients with gastrointestinal, neurological, other comorbidities, and/or complications were noted. Complications were included with comorbidities as they may have influenced decision-making regarding placement of tracheostomy. The timing of the decision for tracheostomy was often impossible to determine from the medical record. Outcomes were determined from medical record review and through query of the outpatient records/database of the chronic mechanical ventilation program. The time in days from the index CHD surgical operation to tracheostomy was recorded. The proportions of patients requiring gastrostomy or a subsequent CHD surgery during that admission were noted. Patient status was evaluated at hospital discharge including death, alive on positive pressure ventilation, or alive with tracheostomy alone. The time from tracheostomy to hospital discharge and total hospital length of stay (LOS) were collected. Longterm survival and weaning from positive pressure ventilation are reported based on the time from the index CHD surgical operation. There were six surviving patients with less than three years of follow-up. One surviving patient had less than one year of follow-up data as he moved following hospital discharge, and a second moved out of state after two years. The remaining four patients have been seen in clinic in late 2014 or early 2015. Median follow-up for all surviving patients was 6.6 years (interquartile range: 3.8-9.5).
Statistical analysis was performed using STATA 12.1 (Stata Corp, College Station, Texas). Patients in each physiological group were compared using Fisher exact and Kruskal-Wallis testing. Proportions or median values with 25th and 75th percentiles were reported. Time-to-event models among the physiological groups for long-term survival and weaning from positive pressure ventilation were analyzed. Kaplan-Meier curves for survival were performed. Time for weaning from positive pressure ventilation was adjusted for the competing risk of death and reported as the cumulative incidence. 21 Comorbidities and patient characteristics potentially associated with long-term outcomes were evaluated with log-rank tests. Gastrostomy tube placement and lower airway malacia were potentially statistically significant (P < .2) and were included as part of Cox proportional hazard model after testing the proportional hazard assumption. Lower airway malacia was removed from the final model as it did not contribute to model fit.
Results
Over this 14-year period, an estimated 7,000 surgical repairs for CHD were performed. During this period, 61 of these patients (approximate incidence 0.9%) required tracheostomy following their initial cardiac surgery. The distribution of single-ventricle and biventricular physiological categories is shown in Table 1 . The distribution of conotruncal lesions (as a subcategory of biventricular physiology) is also described. Most patients had biventricular lesions unrelated to conotruncal defects. Atrioventricular canals and complex ventricular septal defects were the most common lesions.
Detailed demographic characteristics are highlighted in Table 2 . Overall, patients were 55.7% (34) female and most had CHD surgery during the first six months of life: 37.3% (23) in the first month and 39.3% (24) in the next one to six months. The age distribution between physiological categories was not statistically different. Among single-ventricle patients, 41.7% (five) had CHD surgery <1 month of age, but three (25.0%) patients had CHD surgery at >12 months of age. These patients included a complex single-ventricle patient with tricuspid atresia who initially had a coarctation repair with pulmonary artery band but developed congestive heart failure around a year of age. She had mitral valve repair and central shunt prior to her tracheostomy. The other two complex single-ventricle patients had tracheostomy following the Fontan procedure.
Comorbidities and complications were common among patients requiring tracheostomy following CHD surgery as shown in Table 2 . An identified genetic syndrome occurred in 60.7% (37) of patients, with trisomy 21 being the most common. Specific syndromes such as DiGeorge or Heterotaxy, while commonly associated with specific CHD diagnoses, were found in both physiologic groups. Pulmonary disease including upper airway obstruction, lower airway malacia, and chronic lung disease was common in both groups. Diaphragmatic paralysis was documented in a patient with single-ventricle physiology. Vocal cord paralysis was documented in a patient with truncus arteriosus and DiGeorge syndrome and in another patient with a balanced atrioventricular canal and trisomy 21. Pulmonary hypertension occurred in 59.0% (36) of all patients. Gastrointestinal comorbidities including necrotizing enterocolitis, feeding intolerance, omphalocele, and visceral malposition were common. Neurological comorbidities including hypoxic ischemic encephalopathy, stroke, hydrocephalus, and interventricular hemorrhage were less common. Approximately half of all patients had other comorbidities including failure to thrive, renal disease, intrauterine growth impairment, metabolic disease, and so on. Among patients in either the single-ventricle or biventricular physiology groups, 31.2% (19) required a subsequent CHD surgical procedure prior to discharge. Gastrostomy placement was common in both groups but occurred less commonly (66.7%, eight patients) in singleventricle patients (P ¼ .04).
Overall outcomes for these patients are presented in Table 3 . Tracheostomy occurred at a median of 70 days (38, 95) following the index CHD repair and was not different among the groups. Hospital survival was substantially less in singleventricle patients, 50% (6) versus 85.7% (42) in biventricular patients (P ¼ .01). Only 22.9% (11) of hospital survivors were discharged home without positive pressure ventilation in either group. The median time from tracheostomy to discharge (90 days [53, 144]) and total hospital LOS (195 days [151, 251]) were not different between groups.
Long-term survival is significantly less in single-ventricle patients than in biventricular physiology patients (P ¼ .01; Figure 1 ). Survival at one year is 37% in single-ventricle patients versus 77.6% in biventricular patients. Survival at three years continued to decline to 27.8% and 64.8%, respectively, but was stable up to five years. Of the four surviving single-ventricle patients, two were able to complete the Fontan palliation (one tricuspid atresia and one heterotaxy, unbalanced atrioventricular septal defect [the only single-ventricle patient discharged home off positive pressure ventilation]), one survives with a central shunt after 14 years, and the other had a tracheostomy following his Fontan (subsequently lost to follow up). The three patients with follow-up have been decannulated. Of the demographic characteristics, comorbidities, or complications assessed in both study groups, only gastrostomy tube placement was independently associated with improved survival (hazard ratio: 0.22, P ¼ .002) in all patients using a multivariable Cox proportional hazard model. The cumulative incidence of weaning from positive pressure ventilation was not statistically different but may be lower in single-ventricle patients (Figure 2) . None of the comorbidities impacted weaning from positive pressure ventilation.
Among those patients who died, the cause of death was most frequently attributed to withdrawal of care (57.7%, 15). Withdrawal occurred both during and following the initial hospitalization. Cardiac arrests including tracheostomy events occurred in 30.8% (eight) of patients. Sepsis or multisystem organ failure rarely occurred in 11.5% (three) of patients. There were no differences in the causes of death between singleventricle and biventricular physiology patients.
Comment
This series of patients with tracheostomy following surgery for CHD represents one of the largest single-institution studies to date, with a long period of follow-up. This study compared patients with complex single-ventricle and biventricular physiology, and it demonstrates substantially lower hospital (50.0% vs 85.7%) and long-term survival (three years, 27.8% vs 64.8%) in single-ventricle patients. These findings are similar to previous studies in cardiac populations. In comparison to reported outcomes for other pediatric populations, infants with chronic lung disease from prematurity or respiratory distress syndrome have 80% to 90% survival. Although patients who require CHD repair have potentially more complicated cardiopulmonary interactions, this analysis suggests that tracheostomy may be as useful in patients with biventricular disease as it has been in premature neonates. 15, 17, 18, 20 The reduced survival in single-ventricle patients may be due in part to the complex cardiopulmonary interactions, underlying pulmonary disease, and the required low pulmonary vascular resistance to maintain single-ventricle physiology. In this cohort, single-ventricle patients did not have additional comorbidities or complications that were associated with reduced survival. This study was not designed to identify predictors of patients requiring tracheostomy after CHD surgery, but it continues to suggest that while comorbidities are common in these complex patients, they are not as important as the underlying CHD in determining long-term outcomes. Only gastrostomy tube placement independently improved survival in all groups. Although the mechanism is not clear, it has been previously suggested that improved nutrition and growth impact survival. 22, 23 Although the presence of lower airway malacia may impact survival in a larger cohort, other comorbidities (including neurological disease, chronic lung disease, upper airway disease, and genetic syndromes) are less likely to impact this population.
These results are consistent with other studies indicating that patients with CHD who require tracheostomy have prolonged hospital stays. These prolonged stays continue to put these patients at risk for hospital-acquired infections and ongoing developmental delay, which could not be evaluated in this study. 13 The analysis demonstrated a relatively consistent three-month hospital stay posttracheostomy across all groups. This period of time likely represents the required period of stabilization and training that must occur prior to discharge. The time from CHD surgery to tracheostomy was also just over two months in most patients. This study could not identify whether patients received positive pressure ventilation for the entire period and how many tracheal extubation attempts were made. Other reports have indicated that patients with CHD are endotracheally intubated on mechanical ventilation for one to two months prior to tracheostomy placement. 2, 3, 5 There is debate in the pediatric community regarding the optimal timing of tracheostomy. There may be a benefit to earlier tracheostomy in specific conditions such as trauma or documented upper airway obstruction. 13, 24 No recommendation for the optimal timing can be made for all patients with CHD. Clearer evidence on long-term outcomes may help clinicians and families balance the risks and benefits of earlier tracheostomy based on the patient's physiologic category (single vs biventricular) and the etiology of chronic respiratory failure.
This study also finds that tracheostomy-related events only account for a third of deaths. Most deaths occur as a result of withdrawal of support. Although this study could not evaluate the precise decision-making around withdrawal, five of the eight single-ventricle patients who died did so after withdrawal 
